BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - PDUFA
Alimera Sciences (ALIM) Announces New PDUFA Date For ILUVIEN® 4/14/2014  More...
MannKind Corporation (MNKD) Drops As The FDA Delays Decision On Inhaled Insulin Treatment 4/7/2014  More...
Andarix Receives Orphan Drug Deisgnation From FDA For Small Cell Lung Cancer 3/26/2014  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Receives Notification Of PDUFA Date Extension For Plegridy™ (Peginterferon Beta-1a) 3/18/2014  More...
Salix Pharmaceuticals, Ltd. (SLXP), Pharming Group (PHGUF.PK) Announce Extension Of PDUFA Action Date For RUCONEST® 2/24/2014  More...
Nervous Chelsea Therapeutics, Inc. (CHTP) Still Awaiting News From The FDA On NORTHERA™ 2/18/2014  More...
FDA Delays Trimel BioPharma's CompleoTRT™ PDUFA Date 1/17/2014  More...
FDA Accepts New Drug Application For Gilead Sciences, Inc. (GILD)'s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin's Lymphoma 1/13/2014  More...
Orexigen Therapeutics, Inc. (OREX) Announces June 10, 2014 PDUFA Action Date For Contrave 1/7/2014  More...
Pozen, Inc. (POZN) Announces New PA8140/PA32540 PDUFA Date Of April 25, 2014 12/23/2013  More...
QRxPharma Pty Ltd. Announces 25 May 2014 As New PDUFA Date For MOXDUO® NDA 12/11/2013  More...
FDA Extends Review Of Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hemophilia Drug ALPROLIX™ 12/2/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB), Swedish Orphan Biovitrum Hemophilia Drug Delayed As FDA Seeks More Info 11/13/2013  More...
Keryx Biopharmaceuticals (KERX) Announces PDUFA Goal Date for Zerenex™ New Drug Application 10/21/2013  More...
Investors Cheerful at FDA's Decision to Extend Deadline for AMAG Pharmaceuticals, Inc. (AMAG)'s Feraheme®; Stock Up 5.89% at Market Close (October 17, 2013) 10/17/2013  More...
Auxilium Pharmaceuticals (AUXL) Receives Notification of XIAFLEX® PDUFA Extension 8/28/2013  More...
GlaxoSmithKline (GSK) Diabetes Drug Faces U.S. Approval Delay 8/2/2013  More...
FDA Accepts DURECT Corporation (DRRX)'s NDA for POSIDUR 6/20/2013  More...
German Regulator Rebuffs Sanofi (France) (SAN.PA) Diabetes Drug 6/19/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces FDA Acceptance for Review of RHB-103 NDA for Acute Migraine and PDUFA Goal Date of February 3, 2014 6/18/2013  More...
Alimera Sciences (ALIM) Announces New PDUFA Date for ILUVIEN® 5/1/2013  More...
QRxPharma Pty Ltd. Sets PDUFA Date for MOXDUO® NDA 3/14/2013  More...
Hyperion Therapeutics Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti™ 1/16/2013  More...
Pfizer Inc. (PFE)/Ligand Pharmaceuticals Inc. (LGND) Get PDUFA Date for Menopause Combo 12/14/2012  More...
Aegerion Pharmaceuticals, Inc. (AEGR) Soars as FDA Panel Backs Cholesterol Drug 10/19/2012  More...
FDA Extends Review of Biogen Idec, Inc. (Massachusetts) (BIIB) MS Drug 10/18/2012  More...
A.P. Pharma, Inc. (APPA) Announces PDUFA Action Date for APF530 New Drug Application Resubmission 10/16/2012  More...
Impax Pharmaceuticals (IPXL): FDA Extends Review on Rytary NDA 10/12/2012  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX): FDA OK for FF/VI 9/27/2012  More...
Hyperion Therapeutics Announces Extension of Action Date for Ravicti™ NDA to January 23, 2013 9/6/2012  More...
Medivation, Inc. (MDVN) and Astellas Pharma Inc. (YPH.BE) Get PDUFA Date for Prostate Cancer Drug 8/6/2012  More...
FDA Grants Priority Review for Exelixis, Inc. (EXEL)'s Cabozantinib in Medullary Thyroid Cancer 7/30/2012  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces Adasuve PDUFA Goal Date Of Dec. 21, 2012 7/6/2012  More...
Consumer Group Urges FDA to Reject Arena Pharmaceuticals, Inc. (ARNA) Diet Drug 6/28/2012  More...
Eli Lilly and Company (LLY) Statement on PDUFA Vote by Senate 6/27/2012  More...
If Arena Pharmaceuticals, Inc. (ARNA)'s Lorcaserin is Approved, Buy VIVUS, Inc. (VVUS) 6/27/2012  More...
FDA Receives Repros Therapeutics Inc. (RPRX)' Submission for Special Protocol Assessment Documentation for Pivotal Studies for Androxal(R) 5/17/2012  More...
Arena Pharmaceuticals, Inc. (ARNA) Wins Positive FDA Panel Vote for Obesity Drug 5/14/2012  More...
Gilead Sciences, Inc. (GILD)'s Pill Wins U.S. Panel Backing to Prevent HIV 5/11/2012  More...
Talon Therapeutics, Inc. (TLON.OB) Receives Notification of Three Month PDUFA Date Extension for Marqibo(R) 5/8/2012  More...
Napo Pharmaceuticals, Inc. Comments on FDA Announcing Extension of Crofelemer NDA Priority Review 5/4/2012  More...
Navidea Biopharmaceuticals (NEOP) Release: FDA Extends PDUFA Date for Lymphoseek® by Three 4/3/2012  More...
Talon Therapeutics, Inc. (HNAB)' Marqibo(R) Wins Backing of FDA Advisory Panel 3/23/2012  More...
Napo Pharmaceuticals, Inc. Release: FDA Grants PDUFA Date of June 5, 2012 for Crofelemer 2/8/2012  More...
Talon Therapeutics, Inc. (HNAB)' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012 2/3/2012  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces Extension of the ADASUVE™ PDUFA Goal Date by Three Months 1/23/2012  More...
FDA Sets April 24, 2012 as PDUFA Goal Date for Cell Therapeutics, Inc. (CTIC)' Resubmitted Pixantrone New Drug Application 12/6/2011  More...
FDA Extends Protalix Biotherapeutics, Inc. (PLX)'s Taliglucerase Alfa PDUFA Date to May 1, 2012 12/6/2011  More...
FDA Delays Review of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone 11/18/2011  More...
QRxPharma Pty Ltd. Granted Target Date for FDA Action on MoxDuo® IR NDA: NDA Accepted for Review; PDUFA Date Set for June 25, 2012 11/8/2011  More...
FDA Revises IntelGenx Corp.' CPI-300 PDUFA Date to November 10th 11/7/2011  More...
Takeda Global Research & Development Center, Inc. Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone 11/1/2011  More...
FDA Delays Ruling on Bristol-Myers Squibb Company (BMY), AstraZeneca PLC (AZN) Diabetes Drug 10/28/2011  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) and Elan Corporation PLC (ELN) Receive Notification of PDUFA Date Extension 10/20/2011  More...
Transcept Pharmaceuticals, Inc. (TSPT) Shares Soar on Potential Sleeping Pill Approval; Intermezzo(R) PDUFA Action Date of November 27, 2011 10/5/2011  More...
Discovery Laboratories (DSCO) Notified of PDUFA Date for SURFAXIN(R) 9/28/2011  More...
Amgen (AMGN): FDA to Decide on New Xgeva Use by April 8/26/2011  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces Adasuve (Staccato(R) Loxapine) PDUFA Goal Date of February 4, 2012 8/19/2011  More...
Affymax, Inc. (AFFY) Announces Assignment of March 27, 2012 PDUFA Date for Peginesatide New Drug Application 8/11/2011  More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) and Alkermes (ALKS)'s BYDUREON Reply Submitted to FDA 8/1/2011  More...
IntelGenx Corp. Announces New PDUFA Date for Its Single Dose 450 mg Bupropion Hydrochloride Tablet 6/14/2011  More...
FDA Delays Decision on Pacira Pharmaceuticals, Inc.'s Exparelf 6/14/2011  More...
Lannett Company, Inc. (LCI) Announces Revised FDA PDUFA Date for Morphine Sulfate Oral Solution NDA 6/7/2011  More...
Labeling and Script Use May Cause Problems For Optimer Pharmaceuticals, Inc. (OPTR)'s New Drug 5/27/2011  More...
INSYS Therapeutics Announces NDA PDUFA Date for Fentanyl SL Spray 5/23/2011  More...
Seattle Genetics, Inc. (SGEN) Announces FDA Accepts Brentuximab Vedotin BLA; PDUFA Date Set for August 30, 2011 5/2/2011  More...
Optimer Pharmaceuticals, Inc. (OPTR) Wins FDA Advisory Panel's Backing for Fidaxomicin for Treatment of Patients With Clostridium difficile Infection (CDI) 4/7/2011  More...
FDA Accepts for Review Spectrum Pharmaceuticals, Inc. (SPPI)’s ZEVALIN(R) Submission for the Removal of the Bioscan; Spectrum Establishes PDUFA Date 3/22/2011  More...
FDA Assigns PDUFA Date for Shire plc's FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema 3/21/2011  More...
US FDA Assigns New PDUFA Date for AstraZeneca PLC (AZN)'s BRILINTA (ticagrelor tablets) 2/4/2011  More...
Transcept Pharmaceuticals, Inc. (TSPT) Announces Intermezzo(R) PDUFA Action Date of July 14, 2011 1/31/2011  More...
DURECT Corporation (DRRX), King Pharmaceuticals®, Inc.'s REMOXY(R) New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 1/27/2011  More...
ADVENTRX Pharmaceuticals Inc. (ANX) Receives PDUFA Date for Exelbine NDA 1/19/2011  More...
KV Pharmaceutical Company (KV-A) Updates Status of New Drug Application for Gestiva(TM); FDA Extends PDUFA Date to April 13, 2011 1/12/2011  More...
FDA Delays PDUFA On Human Genome Sciences, Inc. (HGSI) and GlaxoSmithKline (GSK) Lupus Drug Benlysta 12/7/2010  More...
FDA Accepts for Review Spectrum Pharmaceuticals, Inc. (SPPI)’s Response on FUSILEV(R) as a Class 2 Submission, and Establishes April 29, 2011 as PDUFA Action Date 11/29/2010  More...
Salix Pharmaceuticals, Ltd. (SLXP) Says FDA Extends Review of Bowel Syndrome Drug; PDUFA Goal Date Extended by 3 Months 10/4/2010  More...
Endo Pharmaceuticals (ENDP) Receives FDA Priority Review for New Formulation of Long-Acting Oxymorphone Designed to be Crush Resistant; PDUFA Date Set for January 7 9/22/2010  More...
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Says FDA To Take More Time To Review Label Wording for Acthar 9/9/2010  More...
GlaxoSmithKline (GSK), Valeant Pharmaceuticals International (VRX) Face US Delay for Epilepsy Drug, Receives New PDUFA Date 8/31/2010  More...
FDA Panel To Vet Boehringer Ingelheim Corporation Blood Thinner September 20 8/26/2010  More...
Cumberland Pharmaceuticals (CPIX) Announces Extension of FDA Review of Acetadote(R) Supplemental New Drug Application; New PDUFA Date in December 2010 8/23/2010  More...
Arena Pharmaceuticals, Inc. (ARNA)'s Weight-loss Medication Lorcaserin Comparable to Orlistat or Sibutramine, Florida Hospital in Winter Park Study 8/6/2010  More...
Warner Chilcott, PLC (WCRX) Announces 3-Month Extension of PDUFA Date on Next Generation Actonel Product 7/16/2010  More...
Protalix Biotherapeutics Receives PDUFA Date For Taliglucerase Alfa; May Not Rule Until 2011 7/12/2010  More...
Orexigen Therapeutics, Inc. (OREX) Announces Assignment of January 31, 2011 PDUFA Date for Contrave(R) New Drug Application 6/17/2010  More...
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Receives Notification of PDUFA Date Extension to September 11, 2010 6/14/2010  More...
AVANIR Pharmaceuticals (AVNR) Announces Zenvia Review Timeline Established by FDA with PDUFA Date of October 30, 2010 5/17/2010  More...
FDA Advisory Committee to Review Lux Biosciences' Uveitis Candidate Luveniq 5/11/2010  More...
Amylin Pharmaceuticals, Inc. (AMLN), Alkermes plc (ALKS), Eli Lilly and Company (LLY) BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 5/6/2010  More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) and Alkermes (ALKS) Submit Reply to FDA Complete Response Letter for BYDUREON(TM); FDA to Issue New PDUFA Target Date 4/23/2010  More...
FDA Panel to Review VIVUS, Inc. (VVUS) Anti-Obesity Drug QNEXA on July 15, 2010 3/26/2010  More...
Amylin Pharmaceuticals, Inc. (AMLN), Eli Lilly and Company (LLY) Diabetes Drug Faces Crucial FDA Decision 3/10/2010  More...
ISTA Pharmaceuticals, Inc. (ISTA) Receives PDUFA Action Date of October 16, 2010 for FDA Review of Once-Daily XiDay(TM) 3/9/2010  More...
NicOx SA (NCOX.F) Announces FDA Advisory Committee to Discuss Naproxcinod on May 12; PDUFA Date Set for July 24, 2010 3/8/2010  More...
Arena Pharmaceuticals, Inc. (ARNA) Receives PDUFA Date for Lorcaserin NDA 2/26/2010  More...
Amylin Pharmaceuticals, Inc. (AMLN)'s (JOBS) Exenatide Once Weekly New Drug Application Review Extended By FDA; New PDUFA Action Date March 12 2/25/2010  More...
FDA Panel to Review Salix Pharmaceuticals, Ltd. (SLXP) NDA for Xifaxan; NASDAQ Halts Trading in SLXP Stock 2/23/2010  More...
US FDA to Decide on Amgen (AMGN) (JOBS) Osteoporosis Drug, PDUFA Action Date Set to July 25, 2010 2/22/2010  More...
Javelin Pharmaceuticals (JAV)' Receives FDA PDUFA Date for Dyloject NDA 2/17/2010  More...
CombinatoRx, Incorporated (CRXX) Announces Extension of Exalgo Extended-Release Tablets PDUFA Date to March 1, 2010 2/17/2010  More...
Alexza Pharmaceuticals, Inc. (ALXA) Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010 2/11/2010  More...
XenoPort, Inc. (XNPT) Announces Extension of the Horizant PDUFA Date to February 11, 2010 2/10/2010  More...
XenoPort, Inc. (XNPT) Announces Horizant(TM) as Brand Name for XP13512 2/4/2010  More...
FDA Extends Sepracor, Inc. (SEPR) PDUFA Action Date for STEDESA; New Drug Application to April 30, 2010 1/28/2010  More...
Theratechnologies Inc. (TH.TO) Says FDA Delays Fat Drug Review Date 1/26/2010  More...
Theratechnologies Inc. (TH.TO) Reports Date for FDA Advisory Committee Review of the Tesamorelin New Drug Application 1/19/2010  More...
Dendreon Corporation (DNDN) (JOBS) Receives FDA Acknowledgement of Complete Response, PDUFA Date Assigned as May 1, 2010 11/20/2009  More...
GlaxoSmithKline (GSK) (JOBS) and XenoPort, Inc. (XNPT) Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010 11/10/2009  More...
FDA Grants Priority Review for Shire plc's Velaglucerase Alfa for Type 1 Gaucher Disease; PDUFA Date is February 28, 2010 11/4/2009  More...
Acorda Therapeutics (ACOR) (JOBS) Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010 10/23/2009  More...
New PDUFA Action Date Assigned for Labopharm (DDS.TO) Drug; FDA Could Rule in February 8/26/2009  More...
NeurogesX, Inc. (JOBS) Announces New PDUFA Date for Qutenza(TM) New Drug Application 8/7/2009  More...
NeurogesX, Inc. (JOBS) Announces Preliminary Results of FDA-Requested Qutenza(TM) Study; PDUFA Date of August 16, 2009 7/24/2009  More...
FDA Accepts for Review Spectrum Pharmaceuticals, Inc. (SPPI)'s Response on ZEVALIN as a Class 1 Submission, and Establishes September 7, 2009 as Decision Date 7/20/2009  More...
AMAG Pharmaceuticals, Inc. (AMAG) Expects FDA Action on Anemia Drug Within Days 7/1/2009  More...
U.S. FDA Panel Urges Approval of Savient Pharmaceuticals, Inc. (SVNT) Gout Drug; PDUFA Action Date is August 1, 2009 6/18/2009  More...
Dyax Corp. (DYAX) Announces FDA Accepts for Review the Complete Response Submission for DX-88 in Hereditary Angioedema 6/8/2009  More...
AMAG Pharmaceuticals, Inc. Announces New PDUFA Date for Feraheme (ferumoxytol injection) 5/13/2009  More...
AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) Diabetes Drug Onglyza Faces FDA Delay; PDUFA Extended to July 30 4/23/2009  More...
PPD, Inc. (PPDI) Updates Discovery Segment Guidance Regarding Alogliptin; PDUFA Date Remains Unchanged 3/6/2009  More...
FDA Provides PDUFA Target Agency Action Date For GTx, Inc. (GTXI)'s Toremifene 80 mg NDA 3/5/2009  More...
FDA Accepts Nuvo Research Inc. (NRI.TO)'s Resubmission For Pennsaid(R) 2/19/2009  More...
Zogenix, Inc. Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM) - Potential Final Approval July 2009 2/18/2009  More...
FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete 1/29/2009  More...
Review of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Febuxostat New Drug Application Continues Past PDUFA Date 1/20/2009  More...
Ipsen: FDA’s First-Cycle Review of Reloxin(R) Extended 1/7/2009  More...
Spectrum Pharmaceuticals, Inc. (SPPI) Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009 12/1/2008  More...
BioDelivery Sciences International (BDSI) Remains on Schedule for December ONSOLIS Resubmission Following Meeting with FDA 11/19/2008  More...
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Extends METOZOLV(TM) ODT Review Date 11/18/2008  More...
Genzyme Corporation (GENZ) Release: Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval 11/17/2008  More...
FDA Panel Mixed on King Pharmaceuticals®, Inc., Pain Therapeutics (PTIE) Drug; FDA Scheduled to Act By December 10 Under Six-Month Priority Review 11/14/2008  More...
AMAG Pharmaceuticals, Inc. (AMAG) Says FDA Accepts Anemia Drug Response; Shares Soar in Pre-Market Trade; FDA Establishes December 30, 2008 PDUFA Action Date 11/13/2008  More...
FDA Establishes Target Action Date of April 17, 2009 for Potential Approval of Discovery Laboratories (DSCO)' Surfaxin 11/10/2008  More...
KV Pharmaceutical Company (KV-A) Provides Update on Gestiva(TM) PDUFA Date 10/21/2008  More...
Forest Laboratories, Inc. (FRX) (JOBS), Cypress Bioscience Inc. (CYPB) Fibromyalgia Drug Delayed at FDA 10/20/2008  More...
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) (JOBS) Says U.S. Delays Ulcer Drug Decision 10/20/2008  More...
Life Science Weekly inSite (Oct. 6 - 10) 10/13/2008  More...
FDA Will Not Be Able To Complete Its Review Of Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s (JOBS) Alogliptin (SYR-322) NDA By The Prescription Drug User Fee Act (PDUFA) Date Of October 27, 2008; Delay Puts PPD, Inc. (PPDI) Payment On Hold 10/10/2008  More...
Ipsen: FDA's First-Cycle Review of Dysport(R) to Be Completed by Year-End 9/30/2008  More...
NovaDel Pharma (NVD) Announces PDUFA Deadline Extension on Zolpimist(TM) 9/19/2008  More...
EPIX Pharmaceuticals, Inc. (EPIX) to Regain Full Worldwide Commercial Rights For Vasovist(R); PDUFA Date Remains Unchanged 9/4/2008  More...
KV Pharmaceutical Company (KV-A) Expects October Due Date for Preterm Labor Drug Approval 9/2/2008  More...
CV Therapeutics, Inc. (CVTX) (JOBS) Says FDA Continues to Review Ranexa(R) Applications Beyond PDUFA Action Date 7/28/2008  More...
FDA to Rule on Labopharm (DDS.TO)'s Tramadol by January 7/17/2008  More...
Labopharm (DDS.TO) Submits Complete Response to FDA as a Result of Outcome of Appeal Process for Once-Daily Tramadol 7/3/2008  More...
FDA Panel To Discuss Roche Holding AG (RHHBF.PK) Arthritis Drug July 29 6/5/2008  More...
Eli Lilly and Company (LLY) Nears FDA Decision On Key Cardio Drug Prasugrel 6/5/2008  More...
Indevus Pharmaceuticals, Inc. (IDEV) Expects FDA to Request Additional Safety Study of NEBIDO Prior to Approval 6/4/2008  More...
FDA Decision on Amgen (AMGN) Clotting Drug Delayed 4/9/2008  More...
FDA Surprise Might Spark Genentech, Inc. (DNA) 2/6/2008  More...
Skyepharma PLC (SKYE) Announces Research Update; FDA Extends Review Period for Requip(R) 2/5/2008  More...
CV Therapeutics, Inc. (CVTX): FDA to Review Additional Use of Angina Drug 12/7/2007  More...
Spectrum Pharmaceuticals, Inc. (SPPI) Says FDA Extends Action Date for New Drug Review 11/21/2007  More...
Biovail Corporation (BVF) Stock Down after FDA Drug Classification 11/20/2007  More...
Sciele Pharma, Inc. (SCRX) Reports That FDA Extends PDUFA Date on New Sular Formulation to January 2, 2008 11/5/2007  More...
Skyepharma PLC (SKYE) Announces Product Update 11/5/2007  More...
Solvay Pharmaceuticals, Inc. Announces FDA Extension of Tedisamil PDUFA Date 9/26/2007  More...
FDA Accepts New Drug Application for Priority Review of Tibotec Pharmaceuticals Ltd Investigational HIV Treatment TMC125 9/20/2007  More...
Sciele Pharma, Inc. (SCRX) Announces Acceptance by FDA of sNDA for New Sular Formulation 9/4/2007  More...
Cardiome Pharma Corp. (COM.TO) (Jobs) and Astellas Pharma US, Inc. (Jobs) Announce PDUFA Action Date Extended by Three Months 8/30/2007  More...
Adolor Corporation (ADLR) and GlaxoSmithKline (GSK) Say FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI; PDUFA February 10, 2008 8/28/2007  More...
Neurocrine Biosciences, Inc. (NBIX) Announces PDUFA Action Date of December 12, 2007 for Indiplon Capsules 8/22/2007  More...
DOR BioPharma, Inc. (DORB) Announces 3 Month Extension of FDA PDUFA Action Date for orBec(R) New Drug Application to Review Supplemental Data 7/19/2007  More...
An Investor's Guide to the New PDUFA 7/18/2007  More...
Merck & Co., Inc. (MRK) Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R) 6/21/2007  More...
FDA Accepts Spectrum Pharmaceuticals, Inc. (SPPI)'s Satraplatin NDA And Grants Priority Review 4/16/2007  More...
Neurochem, Inc. (NRMX)'s Eprodisate (KIACTA(TM)) PDUFA Date Extended Three Months by FDA 4/11/2007  More...
Someone's Betting On Dendreon Corporation (DNDN) 4/10/2007  More...
IDM Pharma, Inc. (IDMI) Announces Oncologic Drugs Advisory Committee Meeting for Junovan(TM) (Mifamurtide) Will Take Place on May 9, 2007 4/3/2007  More...
Dendreon Corporation (DNDN) Shares Halted Ahead of FDA Meeting 3/29/2007  More...
FDA: Final PDUFA Recommendations Transmitted to Congress Will Strengthen Drug Review and Drug Safety 3/27/2007  More...
Endo Pharmaceuticals (ENDP) and Vernalis PLC (VNLS) Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA 3/16/2007  More...
FDA to Review Arcoxia, Merck & Co., Inc. (MRK)'s (Jobs) Follow-Up to Vioxx 3/5/2007  More...
Pro-Pharmaceuticals, Inc. (PRW) Meeting Scheduled With The FDA; April 11th Meeting To Discuss NDA Submission For Co-administration Of DAVANAT(R) With 5-FU To Treat Cancer Patients 2/23/2007  More...
FDA Panel To Review Pfizer Inc. (PFE) (Jobs) HIV Drug 2/8/2007  More...
FDA Advisory Committee To Review DOR BioPharma, Inc. (DORB)'s orBec(R) For The Treatment Of GI GVHD 1/31/2007  More...
Cipher Pharmaceuticals (DND.TO)'s Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA 1/17/2007  More...
FDA Accepts Encysive Pharmaceuticals (ENCY)' Complete Response To Thelin New Drug Application 12/28/2006  More...
Labopharm (DDS.TO) Submits Response To Approvable Letter For Once-Daily Tramadol To FDA 12/20/2006  More...
Genta Incorporated (GNTA) Announces FDA's Oncology Drug Advisory Committee Will Review Genasense(R) As Treatment For Chronic Lymphocytic Leukemia 7/27/2006  More...
Adeza Biomedical (ADZA) Announces August 29 FDA Advisory Committee Date To Review Gestiva To Prevent Preterm Births 7/18/2006  More...
Nastech Pharmaceutical Company Inc. (NSTK) Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray; FDA Rejects Generic Version Of Miacalcin 7/13/2006  More...
Bradley Pharmaceuticals (BDY) Release: FDA Extends PDUFA Date For Polyphenon(R) E Ointment To October 31, 2006 6/30/2006  More...
Oscient Pharmaceuticals Corporation (OSCI) Announces Meeting Date For FDA Advisory Committee To Address sNDA For Five-Day Treatment Of Acute Bacterial Sinusitis With FACTIVE Tablets 6/28/2006  More...
Salix Pharmaceuticals, Ltd. (SLXP) MoviPrep(R) FDA Action Date Established; PDUFA Is August 2, 2006 6/21/2006  More...
AVANIR Pharmaceuticals (AVNR) Says FDA Delays Drug Review By 90 Days; PDUFA Is October 30, 2006 6/20/2006  More...
FDA Grants Class 1 Review To Encysive Pharmaceuticals (ENCY)' Complete Response To Thelin(TM) (Sitaxsentan Sodium) New Drug Application; PDUFA Is July 24, 2006 6/15/2006  More...
MGI PHARMA, INC. (MOGN) Release: Saforis (TM) NDA Accepted By U.S. FDA For Priority Review; PDUFA Is October 12, 2006 6/13/2006  More...
ZOLINZA(TM), Merck & Co., Inc. (MRK)'s Investigational Medicine For Advanced Cutaneous T-Cell Lymphoma (CTCL), To Receive Priority Review From U.S. FDA 6/8/2006  More...
Sepracor, Inc. (SEPR) Presents Positive Arformoterol Data; Shares Soar; PDUFA Is October 12, 2006. 5/25/2006  More...





 

//-->